Skip to content

Tianhong Li

2 papers in the library · publishing 2011-2013

Papers

Sort Most recent Most cited

Abstract 1183: Phase 0 microdosing trial quantitating DNA adduct formation to identify platinum chemosensitivity: from bench to bedside.

Cancer Research April 15, 2013 Chong-Xian Pan, Sisi Wang, Miaoling He et al.

Abstract: Purpose: DNA adduct formation is a critical step in platinum(Pt)–induced cell death. The goal of this project is to measure carboplatin-DNA adducts after a single non-toxic microdose of [14C]carboplatin, use this information to predict efficacy before cancer patients receive toxic chemotherapy and assess the underlying chemoresistance mechanisms, thus enhancing personalized therapy....

Abstract LB-403: A Phase 0 microdosing clinical trial to identify chemoresistance

Cancer Research April 15, 2011 Chong-Xian Pan, Sisi Wang, Ralph W. de Vere White et al.

Abstract BACKGROUND: As alkylating agents, platinum (Pt) analogs kill cancer cells mainly through induction of DNA damage. We hypothesize that low levels of Pt-induced DNA damage are predictive of chemoresistance. Accelerator mass spectrometry (AMS) is an ultrasensitive method for measuring radiocarbon with 10−18∼21 mole sensitivity. By measuring 14C bound to DNA, AMS detects...